The Structural Biology And Molecular Modeling Techniques Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Structural Biology And Molecular Modeling Techniques Market:
https://www.thebusinessresearchcompany.com/report/structural-biology-and-molecular-modeling-techniques-global-market-report
According to The Business Research Company’s Structural Biology And Molecular Modeling Techniques Global Market Report 2024, The structural biology and molecular modeling techniques market size has grown rapidly in recent years. It will grow from $7.58 billion in 2023 to $9 billion in 2024 at a compound annual growth rate (CAGR) of 18.7%. The growth in the historic period can be attributed to emergence of cryo-electron microscopy, pharmaceutical research and drug discovery, understanding enzyme mechanisms, growth in structural genomics initiatives, validation of drug targets, structural insights into viral proteins, drug resistance studies..
The structural biology and molecular modeling techniques market size is expected to see rapid growth in the next few years. It will grow to $17.39 billion in 2028 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to expansion of fragment-based drug design, advancements in hybrid methods, rapid expansion of structural proteomics, precision medicine applications in oncology, structural biology in neuroscience research, application in rna biology, advancements in structural bioinformatics.. Major trends in the forecast period include integration of artificial intelligence (ai), hybrid methods for structural determination, single-particle analysis in cryo-em, membrane protein structures, open-source software development, nmr spectroscopy, structural biology in personalized medicine, technological advances in x-ray crystallography..
The rising prevalence of chronic diseases is expected to propel the growth of the structural biology and molecular modeling techniques market. Chronic disease often lasts for three months or longer and may worsen with time. The most prevalent chronic diseases are cancer, heart disease, stroke, diabetes, and arthritis. Structural biology is being used to investigate the origins of illness, and structure-guided approaches have demonstrated that they contribute to many aspects of early drug discovery, both computationally and empirically. The structure can aid in understanding the effects of human genetic sickness mutations and the effects of cancer and infectious disease treatment resistance. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, there would be 142.66 million people with chronic diseases worldwide by the year 2050, up from 71.522 million in 2020. Therefore, the rising prevalence of chronic diseases is driving the growth of the structural biology and molecular modeling techniques market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8532&type=smp
The structural biology and molecular modeling techniques market covered in this report is segmented –
1) By Tools: SaaS And Standalone Modeling, Visualization And Analysis, Databases, Other Tools
2) By Application: Drug Development, Drug Discovery, Other Applications
3) By End-Users: Pharmaceutical, Biotechnological, Academic, Clinical Trial
Technological advancements are the key trend gaining popularity in the structural biology and molecular modeling techniques market. Major companies operating in the market are developing innovative technologies such as next-generation sequencing-based ctDNA Testing, silico screening of 3-D chemical structures, advanced software, and others to sustain their position in the market. For instance, in March 2022, PerkinElmer Inc., a US-based provider of products, solutions, and services to the applied services, life sciences, and diagnostics markets introduced ChemDraw V21 software that enables quick native import, animation, and sharing of 3D chemical structures in Microsoft PowerPoint. The essential improvement makes it quicker and simpler for chemists to produce more insightful research reports. By using the brand-new ChemDraw V21 software, scientists may easily paste a live 3D rendition of their molecule into the Microsoft PowerPoint program, where they can see, rotate, and share the image with its atom and bond color highlights fully preserved.
The structural biology and molecular modeling techniques market report table of contents includes:
Executive Summary
Structural Biology And Molecular Modeling Techniques Market Characteristics
Structural Biology And Molecular Modeling Techniques Market Trends And Strategies
Structural Biology And Molecular Modeling Techniques Market - Macro Economic Scenario
Global Structural Biology And Molecular Modeling Techniques Market Size and Growth
.
.
.
Global Structural Biology And Molecular Modeling Techniques Market Competitive Benchmarking
Global Structural Biology And Molecular Modeling Techniques Market Competitive Dashboard
Key Mergers And Acquisitions In The Structural Biology And Molecular Modeling Techniques Market
Structural Biology And Molecular Modeling Techniques Market Future Outlook and Potential Analysis
Appendix
Top 5 Major Key Players Are:
Thermo Fisher Scientific Inc
Agilent Technologies Inc
Agile Molecule Inc
Bruker Corporation
Dassault Systèmes SE
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The rising presence of contract research organizations, increasing healthcare IT spending, and unprecedented evolution of the healthcare infrastructure and standards, rise in the prevalence of chronic diseases are key factors contributing to high CAGR of structural biology and molecular modeling during the forecast period.According to the current analysis of Reports and Data, the global structural biology and molecular modeling market was valued at USD 4.00 billion in 2018 and is expected to reach USD 14.97 billion by the year 2026, at a CAGR of 17.9%.
The global structural biology and molecular modeling market is an essential part of the worldwide healthcare sector and has already made vital contributions in obtaining remedies to several diseases.
The structural biology and molecular modeling field are concerned with an arrangement of various molecules in biological compounds and how the peculiarity of the arrangement affects the nature of the compound.
The field also shows different alterations in the structure of the compounds affecting their environment and showing the position of each part of the structure, which is linked to the overall nature of the compound.Improving the quality of medicine and healthcare, in general, has been a key focus of governments across the world in recent years due to the rising volume of patient demographics and the growing geriatric population.
The high cost of equipment may hamper the market growth.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2233The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply & demand patterns.
It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.Key companies profiled in the report include:AlDassault Systemes, Agile Molecule, Accellera Ltd., Bioinformatic LLC, Affymetrix, Agilent Technologies, Inc., Illumina, Bruker Daltonics Inc., Biomax Informatics AG, Chemical Computing Group, and CLC bioMarket Segmentation by Types:Tools (Revenue, USD Million; 2016–2026)SaaS & standalone modelingHomology modelingThreadingMolecular dynamicsAb InitioHybridOthersVisualization & analysisDatabasesOthersMarket Segmentation by Applications:Application (Revenue, USD Million; 2016–2026)Drug developmentDrug discoveryOthersRequest a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2233Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Structural Biology and Molecular Modeling market in each region for the forecast period of 2021-2028.
The report segments the market to help readers get a more in-depth understanding of the different aspects of the market.The report also examines the financial standing of leading companies in detail, which consists of market position, gross profit, overall revenue, sales volume, manufacturing, growth rate, and other vital facts & figures.
The study also highlights production capacity, consumer base, value, volume, product offerings, upstream suppliers, downstream buyers, market concentration rate, and leading regions to give an exhaustive evaluation of the global landscape.The research study consists of the latest updates about the COVID-19 impact on the Structural Biology and Molecular Modeling sector.
The outbreak has virtually influenced the entire global economic landscape.
The report evaluates the current situation of the business and studies the possible aftereffects of the outbreak on the overall industry.Get a Sample Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2233Leading Structural Biology and Molecular Modeling manufacturers/companies in the market:AlDassault Systemes, Agile Molecule, Accellera Ltd., Bioinformatic LLC, Affymetrix, Agilent Technologies, Inc., Illumina, Bruker Daltonics Inc., Biomax Informatics AG, Chemical Computing Group, and CLC bioScope of the ReportStructural Biology and Molecular Modeling product types, applications, end-user industries, and regions are the key market segments studied in this report.
It discusses the growth prospects of different market segments by examining the current market setting, historical performance, demand and supply ratio, production, consumption, sales, and revenue of leading companies in the market.
The regional analysis of the market maps the regions of North America, Europe, Asia Pacific, Latin America, and Middle East & Africa that have been outlined in the research.To summarize, the global Structural Biology and Molecular Modeling market report studies the current market landscape to forecast the growth prospects, challenges, opportunities, risks, and trends observed in the market that can influence industry growth.
